What should be considered when choosing a drug for local therapy of nonspecific vaginitis and bacterial vaginosis

Мамчур, В. И.; Khomiak, O. V.

doi:10.30841/2708-8731.1.2022.258132

Cited by 2 publications

(4 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Своєчасне виявлення та корекція порушень мікробіоценозу пологових шляхів є вкрай важливим елементом у профілактиці низки акушерських та перинатальних ускладнень. Збалансований підхід у лікуванні дисбіозу піхви полягає у використанні сучасних комбінованих антисептичних препаратів для місцевого лікування, що не містять антибактеріальних компонентів та є безпечними для застовування під час всієї вагітності [10,16,22,28,31].…”

Section: а к у ш е р с т в оunclassified

Modern trends in the treatment of bacterial vaginosis in primigravida in the first half of gestation

Beniuk,

Hychka,

Kovaliuk

et al. 2024

RHW

View full text Add to dashboard Cite

Pregnancy with bacterial vaginosis (BV) is accompanied by a high risk of various obstetric and perinatal complications, including miscarriage, preterm birth, placental dysfunction, premature rupture of membranes, chorionamnionitis, polyhydramnios, etc. Screening for BV is carried out in the first half of pregnancy during the registration of a woman, however, taking into account the gestational age, many drugs with antimicrobial and antiseptic effects are categorically contraindicated, as they have an embryo- and fetotoxic effect.Timely detection and correction of microbiocenosis disorders of the birth canal is an extremely important element to prevent a number of obstetric and perinatal complications. A balanced approach in the treatment of vaginal dysbiosis consists in the use of modern combined antiseptic preparations for local treatment, which do not contain antibacterial components and are safe for use during pregnancy.The objective: to determine the effectiveness of the treatment of BV in primigravida women in the first half of pregnancy.Materials and methods. 126 primigravida women aged 18–35 years in the first half of pregnancy were examined during pregnancy registration. The participants were selected randomly.The main group included 36 primigravida women with a gestation period of up to 20 weeks with a diagnosis of BV according to the Amsel and Hay–Ison criteria, who were treated with a combined antiseptic drug (chlorhexidine and chlorophyllipt) – suppository vaginally twice a day, the course of treatment – 5 days. The control group included 30 primigravida women with a gestational age of up to 20 weeks with vaginal normocenosis.For all women the pH of vaginal secretions was determined, followed by microscopy of a native smear, stained according to Gram, and a cultural study was performed. Adherence to the Amsel criteria was also determined, followed by evaluation by the Hay–Ison criteria. The clinical effect was evaluated according to clinical examination data before and on the 6th day of treatment with a combined antiseptic drug (chlorhexidine and chlorophyllipt) using bacterioscopic and bacteriological methods.Results. A normal pH was observed only in every fifth part of examined pregnant woman (28 women – 22.2%), while in the rest patients the acidity of the vaginal environment was not normal. Normocenosis was observed only among 1/3 of primigravida women (37 women – 29.4%). A third of the patients were diagnosed with BV (36 women - 28.6%), every fifth pregnant woman – vulvovaginal candidiasis (28 women - 22.2%).In healthy pregnant women (control group, n=30), the main component of the microbiocenosis was Lactobacillus spp. with a small content of facultatively anaerobic microorganisms. In the main group Atopobium vaginae (38.9%), Gardnerella vaginalis (33.3%), Prevotella bivia (27.8%), Candida spp. (22.2%), as well as Lactobacillus spp. in low titers were dominated. Before the treatment all 36 pregnant women of the main group corresponded to the 3rd type according to the Hay–Ison criteria with the dominance of Gardnerella vaginalis and/or Mobiluncus morphotypes and a small number or complete absence of lactobacilli, which served as the basis for establishing the diagnosis of BV. After treatment type 1 (94.4%) was found in 34 pregnant women, and type 2 (5.6%) – in 2 pregnant women.The results of the microbiological study indicate the normalization of the content of the biotope with the predominance of Lactobacillus spp. in women of the main group, in whom the indicators were similar to the control group.Conclusions. Since pregnancy with BV is accompanied by a high risk of obstetric and perinatal complications, the premorbid background of which is laid already in the first half of pregnancy, there is an urgent need to carry out the birth canal sanitation. The drugs of choice for the BV in the first half of pregnancy are local combined agents of a wide spectrum of action.A universal antiseptic with an anti-inflammatory effect, which includes two components – chlorhexidine and chlorophyllipt, fully meets the recommendations for efficiency and safety and can be used for the BV in the first half of pregnancy.

show abstract

Section: а к у ш е р с т в оunclassified

Modern trends in the treatment of bacterial vaginosis in primigravida in the first half of gestation

Beniuk,

Hychka,

Kovaliuk

et al. 2024

RHW

View full text Add to dashboard Cite

show abstract

“…Th e Eff ect of Probiotic Th erapy on the Vagina Microbiota and the Humoral Link of Immunity in Bacterial Vaginosis Th e normal vaginal microbiota is a dynamic population of various microorganisms, with a predominance of lactobacilli, which provide colonization resistance of the vaginal mucosa as they perform antimicrobial, fermentative, immunoregulatory functions, and more. Th e vaginal microbiota includes various anaerobic and aerobic microorganisms, such as Lactobacillus spp., Bacteroides spp., Prevotella spp., Mobiluncus spp., Veillonella spp., Peptostreptococcus spp., Atopobium vaginale, and others [1,2]. According to the International Classifi cation of Diseases and Related Health Problems, Tenth Revision (ICD-10), and sexually transmitted infections (STIs), opportunistic members of the urogenital microbiota have signifi cant clinical signifi cance.…”

mentioning

confidence: 99%

“…Spivak, A.S. Sverstiuk, L.M. Lazarenko forming biofi lms and resistant to many modern antibacterial drugs [2,3,4,6,7,8].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Effect of Probiotic Therapy on the Vagina Microbiota and the Humoral Link of Immunity in Bacterial Vaginosis

et al. 2023

View full text Add to dashboard Cite

The aim of the research is to determine the effect of the probiotic preparation «Dialak» (dietary supplement), which includes the strain Lactobacillus casei IMV B-7280, on the vaginal microbiota and humoral immunity in women with bacterial vaginosis (BV). Methods. 40 female patients aged 20—45 years with disturbed vaginal microbiota and 10 healthy individuals were examined. The verification of 3 types of vaginal biocenosis states, namely normocenosis, intermediate type, and vaginal dysbiosis, was carried out on the basis of the Recommendations for the Treatment of Sexually Transmitted Infections Weekly Morbidity and Mortality Report (2021) and laboratory diagnostic methods according to the well-known criteria proposed by R. Amsel. Female patients with an intermediate type of BV (group 1) received suppositories and capsules of the probiotic (once daily) for 10 days. Women with vaginal dysbiosis (group 2) received metronidazole in a dosage of 500 mg twice a day for 7 days during the first stage, and then 1 suppository at night and oral capsules of the probiotic in the morning for 10 days during the second stage. The studied vaginal secretion was stained by the Gram method in the Kopeloff modification and also sown on nutrient media to determine facultatively anaerobic and obligately anaerobic microorganisms. Microorganism identification was carried out on the basis of morphological, cultural, biochemical, and antigenic properties according to the classification of D. H. Bergey (2009). The activity of humoral immunity was determined by evaluating the number of B-lymphocytes in the peripheral blood of patients using flow cytometry, as well as the levels of serum Ig A, M, and G before treatment and aft er 1 month using the immunoturbidimetric method and the Cobas 6000 test system from Roche Diagnostics (Switzerland). Results. When analyzing the vaginal microbiota in two groups of patients before treatment, a decrease in the number of Lactobacillus spp. and Bifidobacterium spp. and a significant increase in the number of obligate anaerobic microorganisms, including Gardnerella vaginalis, were found compared to the control group. Before treatment, the number of Lactobacillus spp. in women of group 2 was lower compared to group 1. In patients with vaginal dysbiosis before treatment, the number of obligate anaerobic microorganisms was higher than in patients with bacterial vaginosis, except for Eubacterium spp. At the same time, in women in both comparison groups, the indicators of the humoral immune response were partially disrupted, as evidenced by a decrease in the level of IgG and IgA (in women of group 2) in the serum against the normal level of B lymphocytes (CD19+ cells). However, these patients showed an increase in the IgM level in the serum, which may be due to the development of anaerobic microflora. After treatment, the number of Lactobacillus spp. and Bifidobacterium spp. in the vagina of women in both comparison groups increased compared to the indicators before treatment. However, the number of these bacteria in the vagina of patients with dysbiosis remained lower compared to patients with BV. In both groups, normalization of the number of obligate anaerobic microorganisms, including G. vaginalis, except for Veillonella spp., was also observed. After treatment, the humoral immune response indicators were normalized as well: the level of serum IgG and IgA increased, and the content of serum IgM decreased. Conclusions. In BV patients, the probiotic «Dialak» normalizes the vaginal microbiota, which was confirmed by increasing the number of Lactobacillus spp. and Bifidobacterium spp. along with decreasing the number of anaerobic microorganisms, including G. vaginalis, against the background of the dynamic disappearance of clinical signs of the disease, as well as restoration to the normal level of indicators of the immunity humoral link. The obtained data indicate the effective therapeutic effect of the probiotic «Dialak» on BV.

show abstract

What should be considered when choosing a drug for local therapy of nonspecific vaginitis and bacterial vaginosis

Cited by 2 publications

References 20 publications

Modern trends in the treatment of bacterial vaginosis in primigravida in the first half of gestation

Modern trends in the treatment of bacterial vaginosis in primigravida in the first half of gestation

Effect of Probiotic Therapy on the Vagina Microbiota and the Humoral Link of Immunity in Bacterial Vaginosis

Contact Info

Product

Resources

About